GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (LTS:0RPD) » Definitions » Gross-Profit-to-Asset %

Vifor Pharma AG (LTS:0RPD) Gross-Profit-to-Asset % : 24.89% (As of Dec. 2021)


View and export this data going back to 2014. Start your Free Trial

What is Vifor Pharma AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Vifor Pharma AG's annualized Gross Profit for the quarter that ended in Dec. 2021 was CHF1,246 Mil. Vifor Pharma AG's average Total Assets over the quarter that ended in Dec. 2021 was CHF5,008 Mil. Therefore, Vifor Pharma AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2021 was 24.89%.


Vifor Pharma AG Gross-Profit-to-Asset % Historical Data

The historical data trend for Vifor Pharma AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Gross-Profit-to-Asset % Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.20 21.71 21.72 21.70 22.36

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.58 20.35 23.75 20.92 24.89

Competitive Comparison of Vifor Pharma AG's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vifor Pharma AG's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's Gross-Profit-to-Asset % falls into.



Vifor Pharma AG Gross-Profit-to-Asset % Calculation

Vifor Pharma AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2021 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2021 )/( (Total Assets (A: Dec. 2020 )+Total Assets (A: Dec. 2021 ))/ count )
=1152.8/( (5211.7+5099.6)/ 2 )
=1152.8/5155.65
=22.36 %

Vifor Pharma AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2021 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2021 )/( (Total Assets (Q: Jun. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=1246.4/( (4916.3+5099.6)/ 2 )
=1246.4/5007.95
=24.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2021) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Vifor Pharma AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (LTS:0RPD) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (LTS:0RPD) Headlines

No Headlines